Amylyx Pharmaceuticals Equity 2024

Equity Details

Analyzing Amylyx Pharmaceuticals's Equity

Amylyx Pharmaceuticals's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Amylyx Pharmaceuticals's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Amylyx Pharmaceuticals's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Amylyx Pharmaceuticals's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Amylyx Pharmaceuticals’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Amylyx Pharmaceuticals stock

What is the equity of Amylyx Pharmaceuticals this year?

Amylyx Pharmaceuticals has equity of 433.43 M USD this year.

What was the equity of Amylyx Pharmaceuticals compared to the previous year?

The equity of Amylyx Pharmaceuticals has increased/decreased by 27.26% increased compared to the previous year.

What impact does a high equity have on investors of Amylyx Pharmaceuticals?

A high equity is advantageous for investors of Amylyx Pharmaceuticals as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Amylyx Pharmaceuticals?

A low equity can be a risk for investors of Amylyx Pharmaceuticals, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Amylyx Pharmaceuticals affect the company?

An increase in equity of Amylyx Pharmaceuticals can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Amylyx Pharmaceuticals affect the company?

A reduction in equity of Amylyx Pharmaceuticals can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Amylyx Pharmaceuticals?

Some factors that can affect the equity of Amylyx Pharmaceuticals include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Amylyx Pharmaceuticals so important for investors?

The equity of Amylyx Pharmaceuticals is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Amylyx Pharmaceuticals take to change the equity?

To change equity, Amylyx Pharmaceuticals can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Amylyx Pharmaceuticals pay?

Over the past 12 months, Amylyx Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Amylyx Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Amylyx Pharmaceuticals?

The current dividend yield of Amylyx Pharmaceuticals is .

When does Amylyx Pharmaceuticals pay dividends?

Amylyx Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Amylyx Pharmaceuticals?

Amylyx Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Amylyx Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Amylyx Pharmaceuticals located?

Amylyx Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Amylyx Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Amylyx Pharmaceuticals from 9/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.

When did Amylyx Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/9/2024.

What was the dividend of Amylyx Pharmaceuticals in the year 2023?

In the year 2023, Amylyx Pharmaceuticals distributed 0 USD as dividends.

In which currency does Amylyx Pharmaceuticals pay out the dividend?

The dividends of Amylyx Pharmaceuticals are distributed in USD.